Symbol
CRVS on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%
Shares, Excluding Options vs Price
Value, Excluding Options

SAMLYN CAPITAL, LLC ownership in Corvus Pharmaceuticals, Inc. Common Stock (CRVS)

14 Aug 2025 - SAMLYN CAPITAL, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Corvus Pharmaceuticals, Inc. Common Stock (CRVS). This represents 0% ownership of the company. In their previous filing dated 15 May 2025, SAMLYN CAPITAL, LLC had reported owning 4,065,935 shares, indicating a decrease of +100%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.